CN116322644A - 用环糊精治疗心血管疾病的方法 - Google Patents

用环糊精治疗心血管疾病的方法 Download PDF

Info

Publication number
CN116322644A
CN116322644A CN202180053234.0A CN202180053234A CN116322644A CN 116322644 A CN116322644 A CN 116322644A CN 202180053234 A CN202180053234 A CN 202180053234A CN 116322644 A CN116322644 A CN 116322644A
Authority
CN
China
Prior art keywords
amount
therapeutically effective
cyclodextrin
hydroxypropyl
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180053234.0A
Other languages
English (en)
Chinese (zh)
Inventor
D·克尔温
J·卡姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beren Treatment Public Welfare Co
Original Assignee
Beren Treatment Public Welfare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Treatment Public Welfare Co filed Critical Beren Treatment Public Welfare Co
Publication of CN116322644A publication Critical patent/CN116322644A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180053234.0A 2020-08-27 2021-08-27 用环糊精治疗心血管疾病的方法 Pending CN116322644A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
US63/071,257 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
CN116322644A true CN116322644A (zh) 2023-06-23

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180053234.0A Pending CN116322644A (zh) 2020-08-27 2021-08-27 用环糊精治疗心血管疾病的方法

Country Status (14)

Country Link
US (2) US20240000826A1 (https=)
EP (1) EP4203974A4 (https=)
JP (1) JP2023543131A (https=)
KR (1) KR20230104119A (https=)
CN (1) CN116322644A (https=)
AU (1) AU2021331487A1 (https=)
CA (1) CA3189915A1 (https=)
CO (1) CO2023003656A2 (https=)
CR (1) CR20230135A (https=)
IL (1) IL300805A (https=)
JO (1) JOP20230043A1 (https=)
MX (1) MX2023002418A (https=)
PE (1) PE20231169A1 (https=)
WO (1) WO2022047249A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
MX371073B (es) * 2012-04-13 2020-01-15 L&F Res Llc Método para utilizar ciclodextrina.

Also Published As

Publication number Publication date
EP4203974A1 (en) 2023-07-05
US20240000826A1 (en) 2024-01-04
CR20230135A (es) 2023-07-19
IL300805A (en) 2023-04-01
AU2021331487A1 (en) 2023-03-16
CO2023003656A2 (es) 2023-08-09
WO2022047249A1 (en) 2022-03-03
PE20231169A1 (es) 2023-07-26
EP4203974A4 (en) 2024-08-07
JP2023543131A (ja) 2023-10-13
US20230091966A1 (en) 2023-03-23
JOP20230043A1 (ar) 2023-02-27
KR20230104119A (ko) 2023-07-07
CA3189915A1 (en) 2022-03-03
MX2023002418A (es) 2023-07-11

Similar Documents

Publication Publication Date Title
CN112996562A (zh) 治疗阿尔茨海默病的方法
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
US20240082242A1 (en) Combination therapies
CN116322644A (zh) 用环糊精治疗心血管疾病的方法
García et al. Anaphylactic shock versus Kounis syndrome in cardiac surgery: Differential diagnosis
US20240398849A1 (en) Methods for the treatment of hypertriglyceridemia with cyclodextrins
US20230375576A1 (en) Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
CN116635007A (zh) 用环糊精预防胆固醇结晶栓塞的方法
JP5648287B2 (ja) 冠動脈の描出能改善剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination